Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-esketamine Combination for Postoperative Pain After Spinal Surgery
NCT07523321Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and esketamine in postoperative pain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of moderate-to-severe pain at 72 hours. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07523321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523321.